Elsight Ltd logo

Elsight Ltd (ELS)

Market Closed
ASX ASX
- Market Cap
- P/E Ratio
- Div Yield
1.38M Volume
- Eps
Want to track ELS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ELS is not paying dividends to its shareholders.
The last earnings report, released on Feb 25, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Elsight Ltd has completed 1 stock splits, with the recent split occurring on Nov 18, 2020.
The company's stock is traded on one exchange.

Elsight Ltd (ELS) FAQ

On which exchange is it traded?

Elsight Ltd is listed on ASX.

What is its stock symbol?

The ticker symbol is ELS.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Elsight Ltd ever had a stock split?

Elsight Ltd had 1 splits and the recent split was on Nov 18, 2020.

Elsight Ltd Profile

Capital Markets Industry
Financials Sector
- CEO
ASX Exchange
Q3464C116 CUSIP
United Kingdom Country
- Employees
- Last Dividend
18 Nov 2020 Last Split
- IPO Date

Overview

Seneca Growth Capital VCT plc is a venture capital trust that focuses on providing growth capital to emerging companies predominantly within the biotechnology sector. Its investment strategy is tailored towards supporting unquoted and quoted MedTech companies that exhibit significant growth potential. The trust maintains a geographical focus on investments within the United Kingdom, Île-de-France, Burgundy in France, and other European Developed Markets. Seneca Growth Capital VCT plc sets high standards for its investment portfolio, targeting companies that have already achieved sales greater than £10 million ($11.90 million), demonstrate a gross margin higher than 50%, and sustain an operating margin exceeding 10%. This disciplined approach ensures that the trust invests in businesses with robust financial health and strong growth prospects.

Products and Services

The key products and services offered by Seneca Growth Capital VCT plc encompass a range of investment solutions designed to support the growth and development of emerging biotechnology and MedTech companies. The trust specializes in:

  • Growth Capital Investments: Provision of capital to early-stage, emerging biotechnology companies that are poised for significant growth. These investments aim to fuel the companies' development, expansion, and commercialization of innovative medical technologies.
  • Support for Unquoted Companies: Seneca Growth Capital VCT plc offers vital financial support to unquoted MedTech companies. This enables these businesses to navigate the challenges of the market, scale their operations, and reach critical milestones without the pressures of public market listing.
  • Investment in Quoted MedTech Companies: Beyond unquoted entities, the trust also invests in publicly traded MedTech companies that demonstrate strong growth potential and financial health. This diversifies the investment portfolio and capitalizes on opportunities within the public sector.
  • Geographic Focus: While the trust primarily focuses on companies based in the United Kingdom, it also extends its investment reach to the Île-de-France and Burgundy regions of France, along with other European Developed Markets. This geographic diversity allows the trust to tap into a wider pool of innovative companies and market opportunities.
  • Stringent Investment Criteria: Seneca Growth Capital VCT plc adheres to strict investment criteria, targeting companies with sales greater than £10 million, a gross margin higher than 50%, and an operating margin over 10%. This ensures that the trust invests in financially stable companies with substantial growth potential.

Contact Information

Address: 12 The Parks
Phone: -